Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
16.69
+0.07 (0.42%)
Nov 20, 2026, 10:01 AM EST - Market open
Xeris Biopharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.5 | 0.55 | -54.84 | -62.26 | -94.66 | -122.73 |
Depreciation & Amortization | 12.84 | 12.69 | 12.63 | 13.16 | 12.67 | 1.88 |
Other Amortization | 3.57 | 3.37 | 3.01 | 2.21 | 1.56 | 0.96 |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.24 | - |
Loss (Gain) From Sale of Investments | - | - | -0.75 | -1.26 | 0.18 | 0.41 |
Stock-Based Compensation | 31.28 | 22.37 | 18.36 | 10.72 | 12.16 | 11.38 |
Other Operating Activities | 30.78 | - | -6.57 | -3.29 | 0.11 | 0.7 |
Change in Accounts Receivable | -14.85 | -10.64 | -1.22 | -8.37 | -13.37 | -6.24 |
Change in Inventory | -9.96 | -19.29 | -8.78 | -14.8 | -7.47 | -7.42 |
Change in Accounts Payable | 1.66 | -0.07 | -9.61 | 6.96 | -4.32 | 5.53 |
Change in Other Net Operating Assets | 24.82 | 19.63 | 10.79 | 9.92 | -9.99 | 19.98 |
Operating Cash Flow | 73.65 | 28.63 | -36.98 | -47.02 | -102.89 | -95.54 |
Operating Cash Flow Growth | 597.54% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.03 | -0.7 | -0.87 | -2.26 | -0.52 | -1.09 |
Cash Acquisitions | - | - | - | - | - | 38.47 |
Investment in Securities | - | - | 5.75 | -3.74 | 34.99 | 60.58 |
Investing Cash Flow | -1.03 | -0.7 | 4.88 | -6 | 34.46 | 97.96 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 50 | - | 146.21 | - |
Long-Term Debt Repaid | - | - | - | - | -43.5 | - |
Net Debt Issued (Repaid) | -23.07 | - | 50 | - | 102.72 | - |
Issuance of Common Stock | 12.26 | 22.27 | 1.73 | 0.58 | 30.84 | 27.84 |
Repurchase of Common Stock | -19.5 | -10.88 | -3.73 | -1.01 | -0.47 | -0.53 |
Other Financing Activities | -2.83 | - | -11.83 | -1.19 | -5.61 | -0.05 |
Financing Cash Flow | -33.14 | 11.39 | 36.17 | -1.61 | 127.47 | 27.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | 39.48 | 39.32 | 4.07 | -54.64 | 59.04 | 29.67 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 72.62 | 27.93 | -37.85 | -49.29 | -103.42 | -96.62 |
Free Cash Flow Growth | 628.02% | - | - | - | - | - |
Free Cash Flow Margin | 19.72% | 9.57% | -18.64% | -30.07% | -93.80% | -194.84% |
Free Cash Flow Per Share | 0.42 | 0.16 | -0.26 | -0.36 | -0.76 | -1.22 |
Levered Free Cash Flow | 51.11 | 25.97 | -31.62 | -19.62 | -65.85 | -28.19 |
Unlevered Free Cash Flow | 64.69 | 40.77 | -15.57 | -5.2 | -58.6 | -24.67 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 24.46 | 27.12 | 26.95 | 27.69 | 10.86 | 7.29 |
Change in Working Capital | 1.68 | -10.36 | -8.82 | -6.29 | -35.15 | 11.85 |